Arnot Health Infectious Disease specialist Dr. Justin Nistico discusses why people shouldn't rely on monoclonal antibody treatments alone to keep them safe from COVID-19, especially for the Omicron variant.
February 3rd, 2022, 5:15 AM
Arnot Health Infectious Disease specialist Dr. Justin Nistico discusses why people shouldn't rely on monoclonal antibody treatments alone to keep them safe from COVID-19, especially for the Omicron variant.
Arnot Health tracks site traffic & interaction with our ads to better serve our users. This data is not related to any healthcare records within our network. We may share tracking data with our business partners. By continuing to use the site you are acknowledging that you've read this notice. Learn more